Clinical Trial Name | Clinical Trial Full Title | Principal Investigator | Project site status | Clinical trials gov number |
---|---|---|---|---|
(Merck) MK-7902-001 / E7080-G000-313 / LEAP-001 | A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma | Hirte, Dr Hal | Open to recruitment | NCT03884101 |